4 Legislative Proposals Reflect Growing Scrutiny Of Pharma IP
Bipartisan legislative momentum in Congress is signaling a renewed effort to address perceived abuses of pharmaceutical patents and pricing mechanisms. A recent package of bills advanced by the U.S. Senate Judiciary...To view the full article, register now.
Already a subscriber? Click here to view full article